{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:37:16Z","timestamp":1792237036993,"version":"4.4.0"},"reference-count":43,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2020,8,3]]},"DOI":"10.1021\/acs.molpharmaceut.0c00444","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T03:33:41Z","timestamp":1593228821000},"page":"3024-3032","source":"Crossref","is-referenced-by-count":14,"title":["Cytochrome-P450-Mediated Drug\n                    <b>\u2013<\/b>\n                    Drug Interactions of Substrate Drugs: Assessing Clinical Risk Based on Molecular Properties and an Extended Clearance Classification System"],"prefix":"10.1021","volume":"17","author":[{"given":"Stefanus J.","family":"Steyn","sequence":"first","affiliation":[{"name":"PDM, Medicine Design, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-6329","authenticated-orcid":true,"given":"Manthena V. S.","family":"Varma","sequence":"additional","affiliation":[{"name":"PDM, Medicine Design, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.7.815"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746020-00003"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.781582"},{"key":"ref4\/cit4","unstructured":"EMA. Guideline on the investigation of drug interactions\n                      . http:\/\/www.emaeuropaeu\/docs\/en_GB\/document_library\/Scientific_guideline\/2012\/07\/WC500129606pdf Committee for Human Medicinal Products (CHMP), London, UK 2012."},{"key":"ref5\/cit5","unstructured":"USFDA. Drug interaction\nstudies - study design, data analysis, implications\nfor dosing, and labeling recommendations\n                      . http:\/\/www.fdagov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm292362pdf Center for Drug Evaluation and Research (CDER), Rockville, MD 2012."},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1021\/jm701122q"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(02)02412-1"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1823"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.117.080044"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-015-1749-4"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.064303"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.595"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.245951"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.252049"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22674"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1021\/mp2004912"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.034918"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-2024-z"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(97)01081-7"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(97)01085-4"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.3109\/03602539308993972"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03115-0"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1038\/nature01862"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M611692200"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2004.11.004"},{"key":"ref26\/cit26","first-page":"61","volume":"12","author":"Beaumont K.","year":"2009","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.020479"},{"key":"ref28\/cit28","first-page":"936","volume":"29","author":"Ekins S.","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500285"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1002\/1521-3838(200210)21:4<357::AID-QSAR357>3.0.CO;2-D"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511232200"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.142"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.520"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.695"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.067744"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.07.080"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.525"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1239-0"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.317"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.06.019"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.054031"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.3.5.667"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.257600"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.0c00444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T04:05:50Z","timestamp":1682568350000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.0c00444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,3]]}},"alternative-id":["10.1021\/acs.molpharmaceut.0c00444"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00444","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738214753.793576567","asserted-by":"object"}]},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}